Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes

per Brinton, Eliot A., Triscari, Joseph, Brudi, Philippe, Chen, Erluo, Johnson-Levonas, Amy O., Sisk, Christine McCrary, Ruck, Rae Ann, MacLean, Alexandra A., Maccubbin, Darbie, Mitchel, Yale B.
Publicat a Lipids Health Dis (2016)

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

per Bays, Harold E, Brinton, Eliot A, Triscari, Joseph, Chen, Erluo, Maccubbin, Darbie, MacLean, Alexandra A, Gibson, Kendra L, Ruck, Rae Ann, Johnson-Levonas, Amy O, O’Neill, Edward A, Mitchel, Yale B
Publicat a Vasc Health Risk Manag (2015)